# Quetiapine (Seroquel XR) for the Treatment of Fibromyalgia: a Clinical and Mechanistic Pilot Study

> **NCT00983320** · PHASE4 · COMPLETED · sponsor: **Université de Sherbrooke** · enrollment: 52 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** quetiapine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00983320
- **Lead sponsor:** Université de Sherbrooke
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2011-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00983320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00983320, "Quetiapine (Seroquel XR) for the Treatment of Fibromyalgia: a Clinical and Mechanistic Pilot Study". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00983320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*